This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1991 Sep;64(3):534-6.

doi: 10.1038/bjc.1991.345.

Reversal of adriamycin resistance by lonidamine in a human breast cancer cell line

G Citro¹, C Cucco, A Verdina, G Zupi

Affiliations

PMID: 1911196
PMCID: PMC1977636
DOI: 10.1038/bjc.1991.345

Free PMC article

Reversal of adriamycin resistance by lonidamine in a human breast cancer cell line

G Citro et al. Br J Cancer. 1991 Sep.

Free PMC article

. 1991 Sep;64(3):534-6.

doi: 10.1038/bjc.1991.345.

Authors

G Citro¹, C Cucco, A Verdina, G Zupi

Affiliation

¹ Laboratory of Experimental Chemotherapy, Regina Elena Institute for Cancer Research, Rome, Italy.

PMID: 1911196
PMCID: PMC1977636
DOI: 10.1038/bjc.1991.345

No abstract available

PubMed Disclaimer

Similar articles

Lonidamine induces apoptosis in drug-resistant cells independently of the p53 gene.
Del Bufalo D, Biroccio A, Soddu S, Laudonio N, D'Angelo C, Sacchi A, Zupi G. Del Bufalo D, et al. J Clin Invest. 1996 Sep 1;98(5):1165-73. doi: 10.1172/JCI118900. J Clin Invest. 1996. PMID: 8787680 Free PMC article.
In vitro potentiation by lonidamine of the cytotoxic effect of adriamycin on primary and established breast cancer cell lines.
Savini S, Zoli W, Nanni O, Volpi A, Frassineti GL, Magni E, Flamigni A, Amadori A, Amadori D. Savini S, et al. Breast Cancer Res Treat. 1992;24(1):27-34. doi: 10.1007/BF01832355. Breast Cancer Res Treat. 1992. PMID: 1463869
An adriamycin-resistant subline is more sensitive than the parent human small cell lung cancer cell line to lonidamine.
Kiura K, Ohnoshi T, Ueoka H, Takigawa N, Tabata M, Segawa Y, Shibayama T, Kimura I. Kiura K, et al. Anticancer Drug Des. 1992 Dec;7(6):463-70. Anticancer Drug Des. 1992. PMID: 1337430
Cellular and molecular effects of adriamycin on dividing and nondividing cells.
Barranco SC. Barranco SC. Pharmacol Ther. 1984;24(3):303-19. doi: 10.1016/0163-7258(84)90007-x. Pharmacol Ther. 1984. PMID: 6379686 Review. No abstract available.
Cell membranes as target for anticancer agents.
Arancia G, Donelli G. Arancia G, et al. Pharmacol Res. 1991 Oct;24(3):205-17. doi: 10.1016/1043-6618(91)90083-a. Pharmacol Res. 1991. PMID: 1956865 Review. No abstract available.

See all similar articles

Cited by

Receptor-mediated oligodeoxynucleotides delivery by estradiol and folic acid polylysine conjugates.
Citro G, Ginobbi P, Szczylik C. Citro G, et al. Cytotechnology. 1993 Jan;11(Suppl 1):S30-4. doi: 10.1007/BF00746048. Cytotechnology. 1993. PMID: 22358703
Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target.
Scambia G, Ranelletti FO, Panici PB, De Vincenzo R, Bonanno G, Ferrandina G, Piantelli M, Bussa S, Rumi C, Cianfriglia M, et al. Scambia G, et al. Cancer Chemother Pharmacol. 1994;34(6):459-64. doi: 10.1007/BF00685655. Cancer Chemother Pharmacol. 1994. PMID: 7923555
Lonidamine induces apoptosis in drug-resistant cells independently of the p53 gene.
Del Bufalo D, Biroccio A, Soddu S, Laudonio N, D'Angelo C, Sacchi A, Zupi G. Del Bufalo D, et al. J Clin Invest. 1996 Sep 1;98(5):1165-73. doi: 10.1172/JCI118900. J Clin Invest. 1996. PMID: 8787680 Free PMC article.
Lonidamine causes inhibition of angiogenesis-related endothelial cell functions.
Del Bufalo D, Trisciuoglio D, Scarsella M, D'Amati G, Candiloro A, Iervolino A, Leonetti C, Zupi G. Del Bufalo D, et al. Neoplasia. 2004 Sep-Oct;6(5):513-22. doi: 10.1593/neo.04133. Neoplasia. 2004. PMID: 15548359 Free PMC article.
Relative cytotoxicities of adriamycin and epirubicin in combination with lonidamine against human bladder cancer cell lines.
Popert RJ, Masters JR, Coptcoat M, Zupi G. Popert RJ, et al. Urol Res. 1995;22(6):367-72. doi: 10.1007/BF00296877. Urol Res. 1995. PMID: 7740656

See all "Cited by" articles

References

1. Cancer Res. 1988 Feb 15;48(4):870-7 - PubMed
1. Cancer Res. 1987 Oct 1;47(19):5141-8 - PubMed
1. J Neurosurg Sci. 1989 Jan-Mar;33(1):55-64 - PubMed
1. Adv Cancer Res. 1989;52:165-203 - PubMed
1. Br J Cancer. 1989 Feb;59(2):251-3 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database